Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
MERIT is an ophthalmology reading center supporting Phase I – IV clinical trials. Our team are experts in managing and evaluating images, especially with ocular diseases affecting the retina. As a trusted partner to sponsors and CROs, we provide domain expertise, innovative imaging tools, and scalable solutions.
With MERIT, your ophthalmology study data and images can easily be shared between clinical sites, reading centers, CROs, and sponsors for maximum transparency. This makes managing global ophthalmic trials involving multiple reading centers and analysis of multiple modalities not only feasible, but practical.
Messages are sent directly to the project team from our data acquisition platform, allowing for smoother tracking of images
Our data acquisition platform makes site queries more efficient.
Immediate quality control enables quick confirmation that images have been acquired correctly
Prompt feedback to the site prevents further images from being acquired incorrectly
MERIT’s comprehensive portfolio of ophthalmic services ensures your research is conducted accurately and efficiently. We seamlessly manage the imaging components of your trial, creating efficiencies for your drug development.
OUR IMAGING SERVICES:
Full, Abbreviated, and Express Certifications for VA Examiners
Full and Express Certifications for VA Rooms
Certificates Maintained in EXCELSIORTM
Confirmation of Acceptable BCVA Equipment
Scheduling, Tracking & Reporting of BCVA Certification Study Activities
Visual Acuity Certifications: ETDRS, Low Luminance, Contrast Sensitivity & Reading Assessments
VA Room Equipment Procurement
MERIT provides ECC analysis for the following ocular clinical trials:
A successful multi-center trial requires intrinsic understanding of various imaging techniques, developing meaningful outcome correlations, and formulating computational methodologies. Our insightful experts (several are board-certified ophthalmologists) help guide your selection of the right biomarkers that accurately reflect the characteristics of disease progression and treatment effects.
Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Learn how MERIT’s imaging expertise and proprietary software play a vital role in gene therapy clinical trials. We leverage our experience supporting 29 gene therapy clinical trials, providing valuable knowledge of specialized modalities...
MERIT’s Imaging Expertise and Proprietary Software Perform a Crucial Role in Global Phase III Wet AMD Study....
MERIT’s cloud-based EXCELSIOR™ platform allows immediate transfer of data directly from qualified sites to a central database for review without installing software or configuring firewalls. Our exceptional reading center services for ophthalmic imaging can be easily configured to meet sponsor and study requirements. EXCELSIOR, built specifically for supporting image data collection and management for ophthalmic clinical trials, offers the latest web and imaging technologies for data standardization, analysis, grading, and reporting.
AMD
Age Related Macular Degeneration (AMD) is a common eye condition and leading cause of vision loss among people aged 50 and over.
UVEITIS
Uveitis refers to the inflammation of structures on the uveal tract and causes 10-15% of cases of legal blindness in the US.
DR/DME
Diabetic Retinopathy/Diabetic Macular Edema (DR/DME) is the most common cause of vision loss among people with diabetes and a leading cause of vision impairment/blindness among working-age adults. Chronically high blood sugar is associated with damage to the blood vessels in the retina.
RVO
Retinal Vein Occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide.
INHERITED RETINAL DISEASES
Therapeutic options are under investigation for the treatment of previously untreatable Rare or Orphan diseases in ophthalmology such as Retinitis Pigmentosa, Usher Syndrome, Stargardt Disease and Leber Congenital Amaurosis.